International Conference on Hematology and Oncology
ICHO
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track focuses on the latest methodologies and technologies in cellular analysis, particularly through flow cytometry. Participants will explore applications in hematology and oncology, emphasizing diagnostic and therapeutic implications.
SDG 3
SDG 4
This session will delve into the role of molecular diagnostics in identifying cancer biomarkers for early detection and personalized treatment. Discussions will include innovative techniques and their impact on patient outcomes.
SDG 3
SDG 4
This track will cover recent advancements in chemotherapy and radiotherapy, including novel chemotherapeutic agents and treatment protocols. Emphasis will be placed on optimizing therapeutic efficacy while minimizing side effects.
SDG 3
SDG 9
Focusing on hematological disorders, this session will address the latest diagnostic techniques and management strategies for conditions such as leukemia and myeloproliferative diseases. The integration of clinical practice with research findings will be highlighted.
SDG 3
SDG 4
This track will explore the unique challenges faced in pediatric oncology, including diagnosis, treatment, and survivorship. Innovative approaches and research in this field will be discussed to improve outcomes for young patients.
SDG 3
SDG 4
This session will focus on the translation of laboratory research into clinical applications in oncology. Participants will examine case studies and strategies to enhance collaboration between researchers and clinicians.
SDG 3
SDG 9
This track will address the ethical dilemmas faced in oncology, including end-of-life care, informed consent, and resource allocation. Discussions will aim to provide frameworks for ethical decision-making in clinical practice.
SDG 3
SDG 16
Focusing on cutting-edge technologies, this session will highlight innovations such as nanoscience and immunotherapy in cancer research. Participants will discuss their potential to revolutionize treatment paradigms.
SDG 3
SDG 9
This track will examine the epidemiological factors contributing to cancer incidence and the effectiveness of prevention strategies. Insights into public health policies and community interventions will be shared.
SDG 3
SDG 4
This session will explore the importance of pain management and palliative care in improving the quality of life for cancer patients. Best practices and innovative approaches to symptom management will be discussed.
SDG 3
SDG 10
Focusing on the role of nursing in oncology, this track will discuss integrative medicine approaches to enhance patient care. Topics will include supportive care strategies and the nurse's role in multidisciplinary teams.
SDG 3
SDG 4